Hepatocyte-specific deletion of Mettl3 drives the progression of NAFL-to NASH in HFD-fed mice by promoting CD36-mediated hepatic free fatty acid uptake and CCL2-induced inflammation. This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatohepatitis.